Immunotherapy for Neurological Post-Acute Sequelae of SARS-CoV-2
Immunotherapy for Neurological Post-Acute Sequelae of SARS-CoV-2
Enrolling by invitation · NCT05350774 · Registry updated 2026-08-26Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Immunotherapy for Neurological Post-Acute Sequelae of SARS-CoV-2 | COVID-19, Chronic Disease, Coronaviridae Infections, Disease Attributes, Infections, Inflammation, Neuroinflammation, Neuroinflammatory Diseases, Nidovirales infectious disease, Orthocoronavirinae infectious disease, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Post-Infectious Disorders, RNA Virus Infections, long COVID-19, lung disorder, nervous system disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia | Enrolling by invitation | Phase 2 | 2026-08-26 | NCT05350774 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Institute of Neurological Disorders and Stroke (NINDS) | 370 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| National Institutes of Health Clinical Center | Bethesda | United States | 800 |